Winning in New Markets: 7 Essentials to Boost the Success of Your Next Market Adjacency Strategy

Fad-Free Strategy co-author Herman Vantrappen shares his approach to making more confident, efficient, and evidence-based business strategy decisions.

A global insurance company was rolling out a new strategic framework with aggressive 2030 goals involving digital transformation, geographic expansion, and revenue growth. In support of this...

An F200 pharma company wanted to implement next generation digital health technologies, which required a thorough review of the existing strategy across three therapeutic areas and a roadmap for...

Innovation expert Steve Wunker joins BTG's Leah Hoffmann to discuss how companies can adapt business strategies to the coronavirus (COVID-19) pandemic and all the upheaval that it has brought.

Organizational culture is directly tied to business performance. Yet only 28% of executives say they understand their company's culture. Here's why—and how to address it.

Innovation is typically seen as a way to boost revenues, but it can also be used to cut costs. Expert Stephen Wunker explains.

You already know it's critical to be able to move quickly. So how can you empower your teams to make fast business decisions?

There's often more focus on the strategic planning process than on actual strategic thought. Create more effective plans with this comprehensive guide.

A VP at a major biopharma company was interested in defining his strategy in the neuroscience space. Looking for a more targeted way to assess the opportunity than big consulting firms could...

Measuring performance is an essential part of management, but there are some right ways and wrong ways to think about metrics. When done right, metrics are essential inputs to decision-making,...

You probably don't need anything else on your plate. But what if there were a few tasks to help you jumpstart your 2020 strategic plan?

A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next...

Not long ago, the EVP of a multinational client called us in to say that his company had recently been through an expensive strategic planning exercise with a major consulting firm. The firm left...